NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球非口服劑包裝市場展望(到2028年)

Global Parenteral Products Packaging Market Outlook 2028

出版商 Research Nester 商品編碼 1023495
出版日期 內容資訊 英文 501 Pages
商品交期: 最快1-2個工作天內
價格
全球非口服劑包裝市場展望(到2028年) Global Parenteral Products Packaging Market Outlook 2028
出版日期: 2021年07月15日內容資訊: 英文 501 Pages
簡介

非口服製劑包裝的全球市場分析(2019年∼2028年)

注射用產品包裝包括用於儲存注射用產品的各種包裝產品。腸胃外產品定義為直接注射到身體組織(例如皮膚和粘膜)中的那些藥物產品。在預測期內,即2021-2028年,全球腸外產品包裝市場預計將以8.8%的年複合成長率成長。醫藥包裝材料的不斷進步以及製藥公司對先進醫藥包裝材料的需求不斷成長等因素。全球非口服劑包裝市場,估計從2019年的約90億美元,到2028年末達約208億美元的收益。

本報告提供全球非口服劑包裝市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔
  • 產品概要

第2章 前提條件與縮寫

第3章 調查手法

  • 調查流程
  • 1次調查
  • 2次調查
  • 市場規模的估計

第4章 分析師檢討

第5章 摘要整理-全球非口服劑包裝市場

第6章 市場系統預測-全球醫藥品包裝市場

第7章 產業的價值鏈分析

  • 原料採購
  • 製造
  • 流通與供給
  • 終端用戶預測
  • 價值鏈整體主要企業的清單

第8章 法規情形

第9章 非口服包裝發展的展望

第10章 COVID-19對非口服製劑包裝市場的影響

第11章 市場動態

  • 成長要素
  • 阻礙因素
  • 趨勢
  • 市場機會

第12章 競爭結構

  • 其他競爭公司的基準
  • 企業的市場佔有率分析,2020年(%)
  • 競爭情形
  • 企業簡介
    • UFP Technologies, Inc.
    • SCHOTT AG
    • Gerresheimer AG
    • UDG Healthcare plc
    • West Pharmaceutical Services, Inc.
    • SiO2 Medical Products Inc.
    • Stevanato Group
    • Berry Global Inc.
    • NIPRO EUROPE GROUP COMPANIES
    • Corning Incorporated

第13章 全球市場的展望

  • 市場規模與預測,2019年∼2028年
    • 以金額為準(百萬美元),2019年∼2028年F
    • 以數量為準(個體),2019年∼2028年F
  • 市場區隔
    • 各材料類型
    • 各產品類型
    • 各包裝形式
    • 藥物的各類型
    • 各地區

第14章 北美市場

  • 市場概要
  • 市場規模,以金額為準(百萬美元)
  • 以數量為準的市場規模(個體)
  • 主要地區的非口服製劑包裝生產者
  • 分銷商預測
  • 價格預測(美金/個體),2018年∼2021年
  • 市場區隔
    • 各材料類型
    • 各產品類型
    • 各包裝形式
    • 藥物的各類型
    • 各國

第15章 歐洲市場

  • 市場概要
  • 市場規模,以金額為準(百萬美元)
  • 以數量為準的市場規模(個體)
  • 主要地區的非口服製劑包裝生產者
  • 分銷商預測
  • 價格預測(美金/個體),2018年∼2021年
  • 市場區隔
    • 各材料類型
    • 各產品類型
    • 各包裝形式
    • 藥物的各類型
    • 各國

第16章 亞太地區市場

  • 市場概要
  • 市場規模,以金額為準(百萬美元)
  • 以數量為準的市場規模(個體)
  • 主要地區的非口服製劑包裝生產者
  • 分銷商預測
  • 價格預測(美金/個體),2018年∼2021年
  • 市場區隔
    • 各材料類型
    • 各產品類型
    • 各包裝形式
    • 藥物的各類型
    • 各國

第17章 南美市場

  • 市場概要
  • 市場規模,以金額為準(百萬美元)
  • 以數量為準的市場規模(個體)
  • 主要地區的非口服製劑包裝生產者
  • 分銷商預測
  • 價格預測(美金/個體),2018年∼2021年
  • 市場區隔
    • 各材料類型
    • 各產品類型
    • 各包裝形式
    • 藥物的各類型
    • 各國

第18章 中東、非洲市場

  • 市場概要
  • 市場規模,以金額為準(百萬美元)
  • 以數量為準的市場規模(個體)
  • 主要地區的非口服製劑包裝生產者
  • 分銷商預測
  • 價格預測(美金/個體),2018年∼2021年
  • 市場區隔
    • 各材料類型
    • 各產品類型
    • 各包裝形式
    • 藥物的各類型
    • 各國
目錄

Global Parenteral Products Packaging Market Analysis 2019-2028

Parenteral products packaging includes the various packaging products that are used to store parenteral products. Parenteral products are defined as those pharmaceutical products which are injected directly into the body tissues, such as the skin, and mucous membranes. The global parenteral products packaging market is anticipated to grow with a CAGR of 8.8% during the forecast period, i.e., 2021-2028. Factors such as the growing advancements in pharmaceutical packaging materials, along with the growing need amongst the pharmaceutical companies for advanced pharmaceutical packaging materials. The global parenteral products packaging market is estimated to garner a revenue of close to USD 20800 Million by the end of 2028, up from around USD 9000 Million in 2019.

The market is segmented by numerous segments, which include segmentation by material type, product type, packaging type, drug type, and by region. Based on material type, the market is segmented into glass and plastic, out of which, the plastic segment is expected to grow with the highest CAGR of 10% approximately during the forecast period. Besides this, the glass segment is further divided into borosilicate glass, aluminosilicate glass, and others, out of which, the borosilicate glass segment is expected to hold the largest market share throughout the forecast period and further attain a revenue of around USD 10200 Million by the end of 2028.

On the basis of regional analysis, the global parenteral products packaging market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa, out of which, the market in the North America region is anticipated to attain the largest market revenue of close to USD 6900 Million by the end of 2028.

Some of the key players in the global parenteral products packaging market that are mentioned in our report are: UFP Technologies, Inc., SCHOTT AG, Gerresheimer AG, UDG Healthcare plc, West Pharmaceutical Services, Inc., SiO2 Medical Products Inc., Stevanato Group, Berry Global Inc., NIPRO EUROPE GROUP COMPANIES, Corning Incorporated, and others.

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation
  • 1.3. Product Overview

2. Assumptions and Acronyms

3. Research Methodology

  • 3.1. Research Process
  • 3.2. Primary Research
  • 3.3. Secondary Research
  • 3.4. Market Size Estimation

4. Analyst Review

5. Executive Summary - Global Parenteral Products Packaging Market

6. Market Lineage Outlook- Global Pharmaceutical Packaging Market

7. Industry Value Chain Analysis

  • 7.1. Raw Material Procurement
  • 7.2. Manufacturing
  • 7.3. Distribution & Supply
  • 7.4. End-User Outlook
  • 7.5. List of Key Players Across the Value Chain

8. Regulatory Landscape

9. Parenteral Packaging Advancement Outlook

10. Impact of Covid-19 on the Parenteral Products Packaging Market

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Restraints
  • 11.3. Trends
  • 11.4. Opportunities

12. Competitive Structure

  • 12.1. Benchmarking of the Competitors
  • 12.2. Company Market Share Analysis, 2020 (%)
  • 12.3. Competitive Landscape
  • 12.4. Company Profiles
    • 12.4.1. UFP Technologies, Inc.
    • 12.4.2. SCHOTT AG
    • 12.4.3. Gerresheimer AG
    • 12.4.4. UDG Healthcare plc
    • 12.4.5. West Pharmaceutical Services, Inc.
    • 12.4.6. SiO2 Medical Products Inc.
    • 12.4.7. Stevanato Group
    • 12.4.8. Berry Global Inc.
    • 12.4.9. NIPRO EUROPE GROUP COMPANIES
    • 12.4.10. Corning Incorporated

13. Global Parenteral Products Packaging Market Outlook

  • 13.1. Market Size and Forecast, 2019-2028
    • 13.1.1. By Value (USD Million), 2019-2028F
    • 13.1.2. By Volume (Units), 2019-2028F
  • 13.2. Market Segmentation
    • 13.2.1. By Material-Type
      • 13.2.1.1. Glass [Borosilicate Glass, Aluminosilicate Glass, Others]; Plastic [Polycarbonate, Polyethylene, Others] 2019-2028F (USD Million)
    • 13.2.2. By Product-Type
      • 13.2.2.1. Ampoules, Cartridges, Pre-Filled Syringes, Vials, Bottles, Bags, 2019-2028F (USD Million & Units)
    • 13.2.3. By Packaging-Type
      • 13.2.3.1. Small Volume Parenterals, Large Volume Parenterals, 2019-2028F (USD Million & Units)
    • 13.2.4. By Drug-Type
      • 13.2.4.1. Insulin, Monoclonal Antibodies, Cytokines, Vaccines, Peptide Hormones, Immunoglobulins, Chemotheraphy Agents, 2019-2028F (USD Million)
    • 13.2.5. By Region
      • 13.2.5.1. North America, Europe, Asia Pacific, Latin America, Middle East & Africa, 2019-2028F (USD Million & Units)

14. North America Parenteral Products Packaging Market Outlook

  • 14.1. Market Overview
  • 14.2. Market Size, By Value (USD Million)
  • 14.3. Market Size, By Volume (Units)
  • 14.4. Leading Regional Parenteral Products Packaging Producers
  • 14.5. Distributor Outlook
  • 14.6. Pricing Outlook (USD/Unit), 2018-2021
  • 14.7. Market Segmentation
    • 14.7.1. By Material-Type
      • 14.7.1.1. Glass [Borosilicate Glass, Aluminosilicate Glass, Others]; Plastic [Polycarbonate, Polyethylene, Others] 2019-2028F (USD Million)
    • 14.7.2. By Product-Type
      • 14.7.2.1. Ampoules, Cartridges, Pre-Filled Syringes, Vials, Bottles, Bags, 2019-2028F (USD Million & Units)
    • 14.7.3. By Packaging-Type
      • 14.7.3.1. Small Volume Parenterals, Large Volume Parenterals, 2019-2028F (USD Million & Units)
    • 14.7.4. By Drug-Type
      • 14.7.4.1. Insulin, Monoclonal Antibodies, Cytokines, Vaccines, Peptide Hormones, Immunoglobulins, Chemotherapy Agents, 2019-2028F (USD Million)
    • 14.7.5. By Country
      • 14.7.5.1. US, Canada, 2019-2028F (USD Million & Units)

15. Europe Parenteral Products Packaging Market Outlook

  • 15.1. Market Overview
  • 15.2. Market Size, By Value (USD Million)
  • 15.3. Market Size, By Volume (Units)
  • 15.4. Leading Regional Parenteral Products Packaging Producers
  • 15.5. Distributor Outlook
  • 15.6. Pricing Outlook (USD/Unit), 2018-2021
  • 15.7. Market Segmentation
    • 15.7.1. By Material-Type
      • 15.7.1.1. Glass [Borosilicate Glass, Aluminosilicate Glass, Others]; Plastic [Polycarbonate, Polyethylene, Others] 2019-2028F (USD Million)
    • 15.7.2. By Product-Type
      • 15.7.2.1. Ampoules, Cartridges, Pre-Filled Syringes, Vials, Bottles, Bags, 2019-2028F (USD Million & Units)
    • 15.7.3. By Packaging-Type
      • 15.7.3.1. Small Volume Parenterals, Large Volume Parenterals, 2019-2028F (USD Million & Units)
    • 15.7.4. By Drug-Type
      • 15.7.4.1. Insulin, Monoclonal Antibodies, Cytokines, Vaccines, Peptide Hormones, Immunoglobulins, Chemotherapy Agents, 2019-2028F (USD Million)
    • 15.7.5. By Country
      • 15.7.5.1. UK, Germany, Italy, France, Spain, Russia, Netherlands, Rest of Europe, 2019-2028F (USD Million & Units)

16. Asia Pacific Parenteral Products Packaging Market Outlook

  • 16.1. Market Overview
  • 16.2. Market Size, By Value (USD Million)
  • 16.3. Market Size, By Volume (Units)
  • 16.4. Leading Regional Parenteral Products Packaging Producers
  • 16.5. Distributor Outlook
  • 16.6. Pricing Outlook (USD/Unit), 2018-2021
  • 16.7. Market Segmentation
    • 16.7.1. By Material-Type
      • 16.7.1.1. Glass [Borosilicate Glass, Aluminosilicate Glass, Others]; Plastic [Polycarbonate, Polyethylene, Others] 2019-2028F (USD Million)
    • 16.7.2. By Product-Type
      • 16.7.2.1. Ampoules, Cartridges, Pre-Filled Syringes, Vials, Bottles, Bags, 2019-2028F (USD Million & Units)
    • 16.7.3. By Packaging-Type
      • 16.7.3.1. Small Volume Parenterals, Large Volume Parenterals, 2019-2028F (USD Million & Units)
    • 16.7.4. By Drug-Type
      • 16.7.4.1. Insulin, Monoclonal Antibodies, Cytokines, Vaccines, Peptide Hormones, Immunoglobulins, Chemotherapy Agents, 2019-2028F (USD Million)
    • 16.7.5. By Country
      • 16.7.5.1. India, China, Vietnam, South Korea, Japan, Singapore, Australia, Rest of Asia Pacific, 2019-2028F (USD Million & Units)

17. Latin America Parenteral Products Packaging Market Outlook

  • 17.1. Market Overview
  • 17.2. Market Size, By Value (USD Million)
  • 17.3. Market Size, By Volume (Units)
  • 17.4. Leading Regional Parenteral Products Packaging Producers
  • 17.5. Distributor Outlook
  • 17.6. Pricing Outlook (USD/Unit), 2018-2021
  • 17.7. Market Segmentation
    • 17.7.1. By Material-Type
      • 17.7.1.1. Glass [Borosilicate Glass, Aluminosilicate Glass, Others]; Plastic [Polycarbonate, Polyethylene, Others] 2019-2028F (USD Million)
    • 17.7.2. By Product-Type
      • 17.7.2.1. Ampoules, Cartridges, Pre-Filled Syringes, Vials, Bottles, Bags, 2019-2028F (USD Million & Units)
    • 17.7.3. By Packaging-Type
      • 17.7.3.1. Small Volume Parenterals, Large Volume Parenterals, 2019-2028F (USD Million & Units)
    • 17.7.4. By Drug-Type
      • 17.7.4.1. Insulin, Monoclonal Antibodies, Cytokines, Vaccines, Peptide Hormones, Immunoglobulins, Chemotherapy Agents, 2019-2028F (USD Million)
    • 17.7.5. By Country
      • 17.7.5.1. Mexico, Brazil, Argentina, Rest of Latin America, 2019-2028F (USD Million & Units)

18. Middle East & Africa Parenteral Products Packaging Market Outlook

  • 18.1. Market Overview
  • 18.2. Market Size, By Value (USD Million)
  • 18.3. Market Size, By Volume (Units)
  • 18.4. Leading Regional Parenteral Products Packaging Producers
  • 18.5. Distributor Outlook
  • 18.6. Pricing Outlook (USD/Unit), 2018-2021
  • 18.7. Market Segmentation
    • 18.7.1. By Material-Type
      • 18.7.1.1. Glass [Borosilicate Glass, Aluminosilicate Glass, Others]; Plastic [Polycarbonate, Polyethylene, Others] 2019-2028F (USD Million)
    • 18.7.2. By Product-Type
      • 18.7.2.1. Ampoules, Cartridges, Pre-Filled Syringes, Vials, Bottles, Bags, 2019-2028F (USD Million & Units)
    • 18.7.3. By Packaging-Type
      • 18.7.3.1. Small Volume Parenterals, Large Volume Parenterals, 2019-2028F (USD Million & Units)
    • 18.7.4. By Drug-Type
      • 18.7.4.1. Insulin, Monoclonal Antibodies, Cytokines, Vaccines, Peptide Hormones, Immunoglobulins, Chemotherapy Agents, 2019-2028F (USD Million)
    • 18.7.5. By Country
      • 18.7.5.1. GCC, South Africa, Israel, Rest of Middle East & Africa, 2019-2028F (USD Million & Units)